There are several data proposing CRP (mean approx. > 80 mg/L) as a marker for diagnosis and prognosis in stomach cancer/gastric carcinoma patients, and that it can independently predict short-term survival for stage IV gastric cancer patients. The gene discussed is CRP; the disease is gastric cancer.